These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31836006)

  • 1. Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
    Zong X; Yang JX; Zhang Y
    J Ovarian Res; 2019 Dec; 12(1):124. PubMed ID: 31836006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
    Germà JR; Llanos M; Tabernero JM; Mora J
    Cancer; 1993 Oct; 72(8):2491-4. PubMed ID: 7691391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
    Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein in malignant germ cell tumors of the ovary.
    Kawai M; Furuhashi Y; Kano T; Misawa T; Nakashima N; Hattori S; Okamoto Y; Kobayashi I; Ohta M; Arii Y
    Gynecol Oncol; 1990 Nov; 39(2):160-6. PubMed ID: 1699854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
    Yoon YM; Kang DY; Kim DY; Seo JW; Lim HJ; Lee HJ; Park SG
    J Med Case Rep; 2016 Jun; 10(1):140. PubMed ID: 27246404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma.
    Wang Y; Zhou F; Qian Z; Qing J; Zhao M; Huang L
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S198-200. PubMed ID: 25518772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
    Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
    Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
    Loh AH; Gee KW; Chua JH
    Pediatr Surg Int; 2013 Jul; 29(7):709-13. PubMed ID: 23653236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
    Ballas M
    Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
    Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
    Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.
    Takemori M; Nishimura R; Yamasaki M; Kawabe Y; Hasegawa K
    Gynecol Oncol; 1998 Jun; 69(3):260-3. PubMed ID: 9648599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
    Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
    J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
    Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitelline components in teratomas and serum alpha-1 fetoprotein].
    Burri M; Hedinger C; Grob PF
    Schweiz Med Wochenschr; 1977 Mar; 107(12):405-10. PubMed ID: 66746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP.
    Talerman A; Haije WG; Baggerman L
    Cancer; 1980 Jul; 46(2):380-5. PubMed ID: 6155988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell tumors of the ovary-lymph node metastases.
    Adcock LL
    Gynecol Oncol; 1986 Feb; 23(2):234-40. PubMed ID: 2417919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of preoperative serum cancer antigen 125 in malignant ovarian germ cell tumors.
    Kim JH; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):236-240. PubMed ID: 29673667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Serum α-Fetoprotein Levels During Different Infection Phases of CHB Patients.
    Yang N; Feng J; Li ZR; Ming KH; Lei XX; Xu BL
    Clin Lab; 2018 Jan; 64(1):43-49. PubMed ID: 29479896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.